Safety and immunogenicity of Lyssavac Berna human diploid cell rabies vaccine in healthy adults
- 31 October 1996
- Vol. 14 (14) , 1361-1365
- https://doi.org/10.1016/s0264-410x(96)00049-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Efficacy study of a new albumin-free Human Diploid Cell Rabies Vaccine (Lyssavac-HDC, Berna) in 100 severely rabies-exposed Thai patientsVaccine, 1995
- Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: A nationwide prospective studyVaccine, 1993
- Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunizationVaccine, 1989
- Post Exposure Studies with Human Diploid Cell Rabies Vaccine and Purified Chick Embryo Cell Vaccine: Comparative Serological Responses in ManZentralblatt für Bakteriologie, 1989
- Rabies Preexposure Prophylaxis with Human Diploid Cell Rabies Vaccine: A Dose-Response StudyThe Journal of Infectious Diseases, 1987
- Preexposure immunization with intradermal human diploid cell rabies vaccine. Risks and benefits of primary and booster vaccinationJAMA, 1987
- Immune complex-like disease in 23 persons following a booster dose of rabies human diploid cell vaccineVaccine, 1986
- A proposed index system for reporting rabies rapid fluorescent focus inhibition test titresJournal of Biological Standardization, 1984
- Human diploid cell rabies vaccine. Effectiveness of immunization with small intradermal or subcutaneous dosesJAMA, 1982
- Human diploid cell rabies vaccine: more protection for less risk?Published by American Medical Association (AMA) ,1980